
Keywords: سوئیچینگ درمان; ACR; American College of Rheumatology; bDMARDs; biologic disease-modifying antirheumatic drugs; DMARDs; disease-modifying antirheumatic drugs; EULAR; European League Against Rheumatism; GRAPPA; Group for Research and Assessment of Psoriasis and Psoriatic